The new SAB BIO name and visual identity are effective as of today; for more information on the company and SAB-142, visit SAB.BIO.
Outlook
The Company confirmed its outlook for fiscal year 2024, as previously disclosed in its May 20, 2024 first quarter earnings press release as well as confirmed its upcoming milestones including a topline data readout from its Phase 1 study of its lead candidate, SAB-142.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.